With Reference to the above mentioned subject it is hereby informed that the trading window for dealing in shares of Aptus Pharma Limited for all designated persons will remain closed from ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aptus Pharma Limited has informed the stock exchange that its trading window for designated persons will remain closed from March 18, 2026 to March 26, 2026 (both days inclusive). The closure is due to two pending matters: an increase in authorized share capital and the consideration and recommendation of a bonus issue of equity shares. A board meeting has been scheduled for Tuesday, March 24, 2026 to discuss these proposals, which will then be subject to shareholder approval. The intimation is filed in compliance with SEBI's Insider Trading Regulations, 2015.
This is a routine insider trading compliance filing, but the underlying signal is positive — the company is actively considering a bonus share issue, which if approved would reward existing shareholders with free additional shares. Investors should watch the March 24 board meeting outcome for confirmation.